Personalized Immunology and Genomics

Personalized immunology integrates genomic insights with immune profiling to tailor therapies to individual patients. This transformative approach is redefining how immune-related diseases are diagnosed, monitored, and treated—enabling earlier detection, prediction of treatment response, and the design of precision-targeted interventions. Leaders in biotech, diagnostics, and data science are harnessing next-generation sequencing (NGS), immune repertoire analytics, and AI-driven platforms to unlock the next era of individualized care.

Key Focus Areas:

  • Immune Repertoire Sequencing (TCR/BCR)
    High-throughput sequencing of T-cell and B-cell receptors to map immune diversity, track clonal expansions, and assess therapy response in cancer, autoimmune disease, and infections.

  • HLA Typing & Compatibility Analysis
    Advanced genotyping platforms for transplant matching, disease risk stratification, and vaccine response prediction.

  • Genomic Biomarkers of Immune Response
    Identification of SNPs, gene expression patterns, and epigenetic markers associated with autoimmune susceptibility, immunotherapy response, and immune deficiency.

  • Single-Cell Multiomics
    Integration of transcriptomics, epigenomics, and proteomics at the single-cell level to decode immune cell behavior in health and disease.

  • Machine Learning & Predictive Immune Modeling
    AI-based platforms that analyze genomic and immunologic data to forecast disease progression, treatment response, or adverse immune events.

  • Personalized Cancer Immunotherapy
    Neoantigen discovery and individualized vaccine design based on tumor-specific mutations and patient-specific HLA profiles.

  • CRISPR & Gene Editing in Immunomodulation
    Precision genome engineering to correct immune defects, enhance T-cell function, or induce antigen-specific tolerance.

  • Multi-Omic Diagnostic Platforms
    Combining genomics, microbiome, metabolomics, and proteomics to create comprehensive immune health profiles.

  • Immune Response Stratification in Clinical Trials
    Genomic and immunologic markers used to stratify patient populations and personalize dosing in immunotherapy development.

  • Others